359 related articles for article (PubMed ID: 24747761)
1. Hydrodynamic delivery of FGF21 gene alleviates obesity and fatty liver in mice fed a high-fat diet.
Gao M; Ma Y; Cui R; Liu D
J Control Release; 2014 Jul; 185():1-11. PubMed ID: 24747761
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 gene transfer reverses body weight gain and fatty liver in obese mice.
Ma Y; Gao M; Sun H; Liu D
Biochim Biophys Acta; 2015 May; 1852(5):1001-11. PubMed ID: 25660446
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice.
Yano K; Yamaguchi K; Seko Y; Okishio S; Ishiba H; Tochiki N; Takahashi A; Kataoka S; Okuda K; Liu Y; Fujii H; Umemura A; Moriguchi M; Okanoue T; Itoh Y
Lab Invest; 2022 Mar; 102(3):281-289. PubMed ID: 34732847
[TBL] [Abstract][Full Text] [Related]
4. Inducible hepatic expression of CREBH mitigates diet-induced obesity, insulin resistance, and hepatic steatosis in mice.
Krumm CS; Xu X; Bare CJ; Holman CD; Kersten S; Dow LE; Lee AH; Cohen DE
J Biol Chem; 2021 Jul; 297(1):100815. PubMed ID: 34023388
[TBL] [Abstract][Full Text] [Related]
5. The Same Metabolic Response to FGF21 Administration in Male and Female Obese Mice Is Accompanied by Sex-Specific Changes in Adipose Tissue Gene Expression.
Makarova E; Kazantseva A; Dubinina A; Jakovleva T; Balybina N; Baranov K; Bazhan N
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638898
[TBL] [Abstract][Full Text] [Related]
6. IL-15/sIL-15Rα gene transfer induces weight loss and improves glucose homeostasis in obese mice.
Sun H; Ma Y; Gao M; Liu D
Gene Ther; 2016 Apr; 23(4):349-56. PubMed ID: 26752354
[TBL] [Abstract][Full Text] [Related]
7. Gdf11 gene transfer prevents high fat diet-induced obesity and improves metabolic homeostasis in obese and STZ-induced diabetic mice.
Lu B; Zhong J; Pan J; Yuan X; Ren M; Jiang L; Yang Y; Zhang G; Liu D; Zhang C
J Transl Med; 2019 Dec; 17(1):422. PubMed ID: 31847906
[TBL] [Abstract][Full Text] [Related]
8. Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice.
Darkhal P; Gao M; Ma Y; Liu D
Int J Obes (Lond); 2015 Aug; 39(8):1292-9. PubMed ID: 25869601
[TBL] [Abstract][Full Text] [Related]
9. Cholic Acid Supplementation of a High-Fat Obesogenic Diet Suppresses Hepatic Triacylglycerol Accumulation in Mice via a Fibroblast Growth Factor 21-Dependent Mechanism.
Ippagunta SM; Kharitonenkov A; Adams AC; Hillgartner FB
J Nutr; 2018 Apr; 148(4):510-517. PubMed ID: 29659970
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endocrine function of classical brown adipose tissue (BAT) in diet-induced obese mice.
Kodo K; Sugimoto S; Nakajima H; Mori J; Itoh I; Fukuhara S; Shigehara K; Nishikawa T; Kosaka K; Hosoi H
PLoS One; 2017; 12(3):e0173661. PubMed ID: 28288167
[TBL] [Abstract][Full Text] [Related]
11. Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta).
Nygaard EB; Møller CL; Kievit P; Grove KL; Andersen B
Int J Obes (Lond); 2014 Feb; 38(2):183-91. PubMed ID: 23736354
[TBL] [Abstract][Full Text] [Related]
12. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant-upregulated mesenchymal stem cells reduce inflammation and improve fatty liver disease in diet-induced obesity.
Domingues CC; Kundu N; Kropotova Y; Ahmadi N; Sen S
Stem Cell Res Ther; 2019 Sep; 10(1):280. PubMed ID: 31477174
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast Growth Factor 21 (Fgf21) Gene Expression Is Elevated in the Liver of Mice Fed a High-Carbohydrate Liquid Diet and Attenuated by a Lipid Emulsion but Is Not Upregulated in the Liver of Mice Fed a High-Fat Obesogenic Diet.
Hao L; Huang KH; Ito K; Sae-Tan S; Lambert JD; Ross AC
J Nutr; 2016 Feb; 146(2):184-90. PubMed ID: 26764334
[TBL] [Abstract][Full Text] [Related]
15. FGF21 gene therapy as treatment for obesity and insulin resistance.
Jimenez V; Jambrina C; Casana E; Sacristan V; Muñoz S; Darriba S; Rodó J; Mallol C; Garcia M; León X; Marcó S; Ribera A; Elias I; Casellas A; Grass I; Elias G; Ferré T; Motas S; Franckhauser S; Mulero F; Navarro M; Haurigot V; Ruberte J; Bosch F
EMBO Mol Med; 2018 Aug; 10(8):. PubMed ID: 29987000
[TBL] [Abstract][Full Text] [Related]
16. Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk.
Liu Y; Dou X; Zhou WY; Ding M; Liu L; Du RQ; Guo L; Qian SW; Tang Y; Yang QQ; Pan DN; Li XY; Lu Y; Cheng JK; Tang QQ
Hepatology; 2021 Oct; 74(4):1864-1883. PubMed ID: 33934381
[TBL] [Abstract][Full Text] [Related]
17. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.
Xu L; Nagata N; Nagashimada M; Zhuge F; Ni Y; Chen G; Mayoux E; Kaneko S; Ota T
EBioMedicine; 2017 Jun; 20():137-149. PubMed ID: 28579299
[TBL] [Abstract][Full Text] [Related]
18. CTRP1 prevents high fat diet-induced obesity and improves glucose homeostasis in obese and STZ-induced diabetic mice.
Ren M; Pan J; Yu X; Chang K; Yuan X; Zhang C
J Transl Med; 2022 Oct; 20(1):449. PubMed ID: 36195912
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese
Makarova E; Kazantseva A; Dubinina A; Denisova E; Jakovleva T; Balybina N; Bgatova N; Baranov K; Bazhan N
Cells; 2021 Dec; 10(12):. PubMed ID: 34943946
[TBL] [Abstract][Full Text] [Related]
20. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]